First Manhattan
BTCY

First Manhattan’s Biotricity, Inc. Common Stock BTCY Stock Holding History

First Manhattan’s Portfolio BTCY Stock Details BTCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-117
Closed – – 1804
2022
Q3 		$0 Hold
117
– – ﹤0.01% 1681
2022
Q2 		$1K Hold
117
– – ﹤0.01% 1523
2022
Q1 		$1K Hold
117
– – ﹤0.01% 1569
2021
Q4 		$2K Buy
+117
New +$2.76K ﹤0.01% 1497

Other funds holding BTCY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
AWM
AE Wealth Management Topeka, Kansas $18.5B AUM 19.51% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SWMP
Signature Wealth Management Partners Montvale, New Jersey $199M AUM 20.2% 1-Year Est. Return

First Manhattan's BTCY Position: Q4 2022 in Review

First Manhattan sold out of Biotricity, Inc. Common Stock (BTCY) in Q4 2022, closing a stake of 117 shares.

First Manhattan first reported a position in BTCY in Q4 2021 and held it in 4 quarters. The position peaked at $2K in Q4 2021. 29 funds tracked by Wall St. Rank hold BTCY as of Q4 2022.

  • First Manhattan reported no remaining Biotricity, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • First Manhattan sold 117 Biotricity, Inc. Common Stock shares in Q4 2022.
  • First Manhattan first reported a position in Biotricity, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
  • First Manhattan's Biotricity, Inc. Common Stock position peaked at $2K in Q4 2021.
  • 29 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q4 2022.

Based on First Manhattan's 13F filing for Q4 2022, filed 14 Feb 2023.